BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38475660)

  • 1. Tumor-infiltrating macrophage associated lncRNA signature in cutaneous melanoma: implications for diagnosis, prognosis, and immunotherapy.
    Wan Q; Deng Y; Wei R; Ma K; Tang J; Deng YP
    Aging (Albany NY); 2024 Mar; 16(5):4518-4540. PubMed ID: 38475660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Senescence-Related lncRNA Signature Predicts Prognosis, Response to Immunotherapy and Chemotherapy in Skin Cutaneous Melanoma.
    Lin K; Zhou Y; Lin Y; Feng Y; Chen Y; Cai L
    Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a pyroptosis-associated long non-coding RNA signature for predicting the immune status and prognosis in skin cutaneous melanoma.
    Wu L; Liu G; He YW; Chen R; Wu ZY
    Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5597-5609. PubMed ID: 34604952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational recognition of lncRNA signature of tumor-infiltrating B lymphocytes with potential implications in prognosis and immunotherapy of bladder cancer.
    Zhou M; Zhang Z; Bao S; Hou P; Yan C; Su J; Sun J
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32382761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine learning-based signature of necrosis-associated lncRNAs for prognostic and immunotherapy response prediction in cutaneous melanoma and tumor immune landscape characterization.
    Cui Z; Liang Z; Song B; Zhu Y; Chen G; Gu Y; Liang B; Ma J; Song B
    Front Endocrinol (Lausanne); 2023; 14():1180732. PubMed ID: 37229449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of ferroptosis-related lncRNA signature and immune-related gene signature for predicting the prognosis of cutaneous melanoma patients.
    Xiong K; Wang Z; Hounye AH; Peng L; Zhang J; Qi M
    Apoptosis; 2023 Jun; 28(5-6):840-859. PubMed ID: 36964478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of m7G-associated lncRNA prognostic signature for predicting the immune status in cutaneous melanoma.
    Rong J; Wang H; Yao Y; Wu Z; Chen L; Jin C; Shi Z; Wu C; Hu X
    Aging (Albany NY); 2022 Jun; 14(12):5233-5249. PubMed ID: 35771136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma.
    Xu Y; Chen Y; Niu Z; Yang Z; Xing J; Yin X; Guo L; Zhang Q; Yang Y; Han Y
    Front Surg; 2022; 9():860806. PubMed ID: 35937602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A model based on immune-related lncRNA pairs and its potential prognostic value in immunotherapy for melanoma.
    Li W; Zhan Y; Peng C; Wang Z; Xu T; Liu M
    Funct Integr Genomics; 2023 Mar; 23(2):91. PubMed ID: 36939945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of an immune-related lncRNA signature as a novel prognosis biomarker for LUAD.
    Chen H; Shen W; Ni S; Sang M; Wu S; Mu Y; Liu K; Li N; Zhu L; Xu G
    Aging (Albany NY); 2021 Aug; 13(16):20684-20697. PubMed ID: 34438369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
    Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
    J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using Immune-Related lncRNA Signature for Prognosis and Response to Immunotherapy in Cutaneous Melanoma.
    Xue L; Wu P; Zhao X; Jin X; Wang J; Shi Y; Yang X; She Y; Li Y; Li C
    Int J Gen Med; 2021; 14():6463-6475. PubMed ID: 34675614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-Talk Between m
    Song W; Ren J; Xiang R; Yuan W; Fu T
    Front Immunol; 2022; 13():740960. PubMed ID: 35350786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
    Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
    Front Immunol; 2022; 13():891175. PubMed ID: 35990668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an IFNγ response-related signature for predicting the survival of cutaneous melanoma.
    Hu B; Wei Q; Li X; Ju M; Wang L; Zhou C; Chen L; Li Z; Wei M; He M; Zhao L
    Cancer Med; 2020 Nov; 9(21):8186-8201. PubMed ID: 32902917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Importance of the lncRNA NEAT1 in Cancer Patients Treated with Immune Checkpoint Inhibitors.
    Toker J; Iorgulescu JB; Ling AL; Villa GR; Gadet JAMA; Parida L; Getz G; Wu CJ; Reardon DA; Chiocca EA; Mineo M
    Clin Cancer Res; 2023 Jun; 29(12):2226-2238. PubMed ID: 37053197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.
    Chen X; Guo W; Xu XJ; Su F; Wang Y; Zhang Y; Wang Q; Zhu L
    J Dermatol Sci; 2017 Mar; 85(3):226-234. PubMed ID: 27955882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
    Tian Q; Gao H; Zhao W; Zhou Y; Yang J
    Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A lncRNA signature of tumor-infiltrating macrophages is associated with prognosis and tumor immunity in lung adenocarcinoma.
    Guo Y; Li G; Xu M; Peng B
    Comput Biol Med; 2022 Sep; 148():105655. PubMed ID: 35715263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer.
    Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z
    Front Immunol; 2022; 13():951455. PubMed ID: 36189298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.